Mar 19, 2018 Cellectar Biosciences Granted Orphan Drug Designation for CLR 131 to Treat Neuroblastoma Learn More
Mar 19, 2018 Cellectar Biosciences to Host 2017 Financial Results and Business Update Conference Call on March 22, 2018 Learn More
Mar 15, 2018 Cellectar Announces Late-Breaking Poster Presentations at AACR 2018 Featuring PDCs and CLR 131 Learn More
Mar 6, 2018 Phase 1 Clinical Data Demonstrating CLR 124 Uptake in Brain Tumors Accepted for Oral Presentation at the 12th World Congress of the World Federation of Nuclear Medicine and Biology Learn More